This open label prospective study investigated the clinical efficacy of chronic prednisone administration in managing congestive heart failure (CHF) patients with diuretic resistance. Thirteen CHF patients received prednisone (1mg/kg daily up to 60mg) and spironolactone (mean 100mg daily) for 4 weeks. The study found that prednisone established diuresis within 3-4 days, reducing body weight and edema. It also improved renal function by decreasing serum creatinine and increasing glomerular filtration rate. While the study had weaknesses like a small sample size and lack of control group, 11 patients were clinically stable on this treatment with decreased mortality. Additional controlled
This open label prospective study investigated the clinical efficacy of chronic prednisone administration in managing congestive heart failure (CHF) patients with diuretic resistance. Thirteen CHF patients received prednisone (1mg/kg daily up to 60mg) and spironolactone (mean 100mg daily) for 4 weeks. The study found that prednisone established diuresis within 3-4 days, reducing body weight and edema. It also improved renal function by decreasing serum creatinine and increasing glomerular filtration rate. While the study had weaknesses like a small sample size and lack of control group, 11 patients were clinically stable on this treatment with decreased mortality. Additional controlled
This open label prospective study investigated the clinical efficacy of chronic prednisone administration in managing congestive heart failure (CHF) patients with diuretic resistance. Thirteen CHF patients received prednisone (1mg/kg daily up to 60mg) and spironolactone (mean 100mg daily) for 4 weeks. The study found that prednisone established diuresis within 3-4 days, reducing body weight and edema. It also improved renal function by decreasing serum creatinine and increasing glomerular filtration rate. While the study had weaknesses like a small sample size and lack of control group, 11 patients were clinically stable on this treatment with decreased mortality. Additional controlled
OVERVIEW • Glucocorticoids have been proven to have potent diuretic effects in animal studies. • Prednisone can rapidly eliminate volume overload and improve clinical status and renal function in CHF with diuretic resistance. • Glucocorticoids regulates the synthesis and release of ANP. • Aim of the study : Was designed to determine the clinical efficacy of chronic administration of prednisone in the management of patients with diuretic resistance. Study design • Open label non-controlled prospective study. (is a type of clinical trial in which both the researchers and participants know which treatment is being administered) Blinding • No blinding. Type of assignment used • All patients received same treatment.
• Prednisone (1mg/kg daily with a maximum dose of 60mg/day) was
administered for 4 weeks.
• Spironolactone ranging from 60mg/day to 180mg/day (mean 100mg/day)
• Number enrolled per group: 13 CHF patients with diuretic resistance.
Assessment • Daily: • Body weight • Supine and seated BP • Pulse rate • Jugular venous distention • Edematous status Inclusion and Exclusion criteria • Inclusion criteria : severe CHF with significant volume overload and diuretic resistance refractory to sequential nephron blockade.
failure , pericardial diseases , prerenal azotemia , hypovolemia, renal disease. Results • After prednisone was added: • Urine volume began to increase • Diuresis established 3 to 4 days after initiating the therapy • Effect persisted during treatment • Body weight reduction (3-9 kg) • Dry weight was achieved on day 20 • Decreased SCr by 48-52 umol/L • Increased GFR 15-33mL/min/1.73m² (P<0.01) CI 95% Study Weaknesses • Lack of control group • Small sample size • Heterogeneity of age and etiology of CHF patients Study strength • 11 patients were clinically stable on the treatment with decreased mortality Conclusion • Prednisone may have potent diuretic effect. • Improve renal function. • Additional studies must be done to ensure efficacy and mechanism of action. • Prednisone can decrease mortality. Any questions? Thank you